Icyiciro cya farumasi API 99% CAS 183133-96-2 Cabazitaxel

Ibisobanuro bigufi:

Cabazitaxel API irashobora kubuza imikurire ya kanseri ndetse ikanatera kanseri kanseri.Kugeza ubu ku isoko, cabazitaxel yakozwe na Sanofi-aventis niwo muti wo ku murongo wa kabiri wa kanseri ya prostate, cyane cyane imiti y’imiti ya sintetike y’imisoro imeze nka molekile ntoya.Hande Bio itanga icyiciro cya farumasi API 99% CAS 183133-96-2 Cabazitaxel.Kubindi bisobanuro, nyamuneka twandikire kumurongo.


Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Cabazitaxel

Numero ya CAS:183133-96-2

Imiti yimiti:C45H57NO14

Ibisobanuro:99%

Ibara:ifu yera cyangwa itari yera

Inkomoko:Igice cya kabiri hamwe na 10-DAB

Ubwoko:APIs

Ubuzima bwa Shelf

Imiterere yububiko: ifunze, irinzwe urumuri, yumutse, igenzurwa nubushyuhe bwicyumba.

Ubushobozi bwo gukora

Inzira y'ibicuruzwa:Iminsi 30-45.

Icyiciro cy'umusaruro:icyiciro kimwe gishobora gutanga hafi 15kg.

Ubushobozi bwo gutanga umusaruro:hari ibarura kandi rishobora kubyara umusaruro.

Hande ibyiza byo gukora

Hande, yubatse ikigo cyayo bwite cya GMP, yatsinze isuzuma ry'amategeko n'amabwiriza ya FDA, EDQM, GMP mu Bushinwa, PMDA mu Buyapani, TGA muri Ositaraliya, Koreya y'Epfo, Ubuhinde, Tayiwani, Ubushinwa, Türkiye, Uburusiya, SGS , Dun & Bradley, nibindi. Muri icyo gihe, isosiyete ifite itsinda ry’ubushakashatsi n’iterambere kandi yagiye ikurikirana patenti nyinshi.Icyumba cyo gupima QC, kumenya neza igeragezwa ryibicuruzwa.

Serivisi zacu

1.Ibicuruzwa:Tanga ibihingwa byujuje ubuziranenge, bifite isuku nyinshi, ibikoresho bya farumasi, hamwe naba farumasi.

2.Serivisi za tekiniki:Ibicuruzwa byabigenewe bifite ibisobanuro byihariye ukurikije ibyo umukiriya asabwa.

Uruganda

Ba umutanga mwiza wibikoresho fatizo ninganda zifite ubunyangamugayo!

Murakaza neza kundeba mwohereza imeri kurimarketing@handebio.com


  • Mbere:
  • Ibikurikira: